{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:04:09Z","timestamp":1779926649631,"version":"3.53.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["TTK220324671"],"award-info":[{"award-number":["TTK220324671"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["Self initiated report(SIR)"],"award-info":[{"award-number":["Self initiated report(SIR)"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46956-2","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:53:30Z","timestamp":1775494410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The evaluation of an HIV-PrEP drug on the vascular health outcomes in a diet-induced prediabetes condition rat model"],"prefix":"10.1038","volume":"16","author":[{"given":"Khanyisa","family":"Maswanganyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amogelang","family":"Sedibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andile","family":"Khathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mlindeli","family":"Gamede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"46956_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","volume":"113","author":"P Balakumar","year":"2016","unstructured":"Balakumar, P., Maung-U, K. & Jagadeesh, G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol. Res. 113, 600\u2013609. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.040 (2016).","journal-title":"Pharmacol. Res."},{"key":"46956_CR2","unstructured":"Organization WH. Cardiovascular diseases (CVDs). (2025)."},{"issue":"1","key":"46956_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson, T. R., Acs, A., Ludwig, C. & Panton, U. H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc. Diabetol. 17 (1), 83. https:\/\/doi.org\/10.1186\/s12933-018-0728-6 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"46956_CR4","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s12325-025-03185-9","volume":"42","author":"K Islam","year":"2025","unstructured":"Islam, K. et al. Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments. Adv. Therapy. 42 (6), 2659\u20132678. https:\/\/doi.org\/10.1007\/s12325-025-03185-9 (2025).","journal-title":"Adv. Therapy"},{"issue":"11","key":"46956_CR5","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1080\/03007995.2022.2101805","volume":"38","author":"U Gottwald-Hostalek","year":"2022","unstructured":"Gottwald-Hostalek, U. & Gwilt, M. Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology. Curr. Med. Res. Opin. 38 (11), 1841\u20131851. https:\/\/doi.org\/10.1080\/03007995.2022.2101805 (2022).","journal-title":"Curr. Med. Res. Opin."},{"key":"46956_CR6","doi-asserted-by":"publisher","unstructured":"Kanter, J. E. & Bornfeldt, K. E. Impact of Diabetes Mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology. 36(6), 1049-53. (2016). https:\/\/doi.org\/10.1161\/ATVBAHA.116.307302","DOI":"10.1161\/ATVBAHA.116.307302"},{"key":"46956_CR7","doi-asserted-by":"publisher","unstructured":"Kolluru, G. K., Bir, S. C. & Kevil, C. G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med.\u00a02012, 918267. (2012). https:\/\/doi.org\/10.1155\/2012\/918267","DOI":"10.1155\/2012\/918267"},{"issue":"10","key":"46956_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"P Rajendran","year":"2013","unstructured":"Rajendran, P. et al. The vascular endothelium and human diseases. Int. J. Biol. Sci. 9 (10), 1057\u20131069. https:\/\/doi.org\/10.7150\/ijbs.7502 (2013).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"46956_CR9","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","volume":"6","author":"S Tangvarasittichai","year":"2015","unstructured":"Tangvarasittichai, S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes. 6 (3), 456\u2013480. https:\/\/doi.org\/10.4239\/wjd.v6.i3.456 (2015).","journal-title":"World J. Diabetes"},{"issue":"11","key":"46956_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/biomedicines9111602","volume":"9","author":"E Hasheminasabgorji","year":"2021","unstructured":"Hasheminasabgorji, E. & Jha, J. C. Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors. Biomedicines 9 (11), 1602 (2021).","journal-title":"Biomedicines"},{"issue":"7","key":"46956_CR11","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/ijms23073645","volume":"23","author":"J-L Wautier","year":"2022","unstructured":"Wautier, J-L. & Wautier, M-P. Vascular Permeability in Diseases. Int. J. Mol. Sci. 23 (7), 3645 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"46956_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fphar.2019.01568","volume":"10","author":"HJ Sun","year":"2019","unstructured":"Sun, H. J., Wu, Z. Y., Nie, X. W. & Bian, J. S. Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide. Front. Pharmacol. 10, 1568. https:\/\/doi.org\/10.3389\/fphar.2019.01568 (2019).","journal-title":"Front. Pharmacol."},{"key":"46956_CR13","doi-asserted-by":"publisher","first-page":"107812","DOI":"10.1016\/j.phrs.2025.107812","volume":"217","author":"S Wei","year":"2025","unstructured":"Wei, S., Evans, P. C., Strijdom, H. & Xu, S. HIV infection, antiretroviral therapy and vascular dysfunction: Effects, mechanisms and treatments. Pharmacol. Res. 217, 107812. https:\/\/doi.org\/10.1016\/j.phrs.2025.107812 (2025).","journal-title":"Pharmacol. Res."},{"key":"46956_CR14","doi-asserted-by":"publisher","unstructured":"Kanmogne, G. D. H. I. V. & Infection Antiretroviral Drugs, and the Vascular Endothelium. Cells 13 (8). https:\/\/doi.org\/10.3390\/cells13080672 (2024).","DOI":"10.3390\/cells13080672"},{"issue":"3","key":"46956_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/CT:4:3:207","volume":"4","author":"BJ Day","year":"2004","unstructured":"Day, B. J. & Lewis, W. Oxidative stress in NRTI-induced toxicity. Cardiovasc. Toxicol. 4 (3), 207\u2013216. https:\/\/doi.org\/10.1385\/CT:4:3:207 (2004).","journal-title":"Cardiovasc. Toxicol."},{"issue":"4","key":"46956_CR16","first-page":"827","volume":"73","author":"MS Islam","year":"2016","unstructured":"Islam, M. S., Venkatesan, V. & EXPERIMENTALLY-INDUCED ANIMAL MODELS OF PREDIABETES AND INSULIN RESISTANCE: A REVIEW. Acta Pol. Pharm. 73 (4), 827\u2013834 (2016).","journal-title":"Acta Pol. Pharm."},{"key":"46956_CR17","doi-asserted-by":"publisher","unstructured":"Khathi, A., Luvuno, M., Mabandla, M. & VOLUNTARY INGESTION OF A HIGH-FAT HIGH-CARBOHYDRATE DIET: A MODEL FOR PREDIABETES. PONTE Int. Sci. Researchs J. 74 https:\/\/doi.org\/10.21506\/j.ponte.2018.5.11 (2018).","DOI":"10.21506\/j.ponte.2018.5.11"},{"key":"46956_CR18","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.hsr.2023.100084","volume":"7","author":"A Ray","year":"2023","unstructured":"Ray, A., Ch. Maharana, K., Meenakshi, S. & Singh, S. Endothelial dysfunction and its relation in different disorders: Recent update. Health Sci. Rev. 7, 100084. https:\/\/doi.org\/10.1016\/j.hsr.2023.100084 (2023).","journal-title":"Health Sci. Rev."},{"key":"46956_CR19","doi-asserted-by":"publisher","unstructured":"Wang, X. & He, B. Endothelial dysfunction: molecular mechanisms and clinical implications. MedComm\u00a05(8), e651. (2020). https:\/\/doi.org\/10.1002\/mco2.651","DOI":"10.1002\/mco2.651"},{"issue":"5","key":"46956_CR20","doi-asserted-by":"publisher","first-page":"e8059","DOI":"10.7759\/cureus.8059","volume":"12","author":"HE Ergin","year":"2020","unstructured":"Ergin, H. E. et al. Antiretroviral Therapy and Metabolic Alterations: A Review. Cureus 12 (5), e8059. https:\/\/doi.org\/10.7759\/cureus.8059 (2020).","journal-title":"Cureus"},{"issue":"1","key":"46956_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-016-0588-4","volume":"14","author":"CA Sabin","year":"2016","unstructured":"Sabin, C. A. et al. Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration. BMC Med. 14 (1), 61. https:\/\/doi.org\/10.1186\/s12916-016-0588-4 (2016).","journal-title":"BMC Med."},{"issue":"6","key":"46956_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1071\/sh18125","volume":"15","author":"I Hodges-Mameletzis","year":"2018","unstructured":"Hodges-Mameletzis, I., Dalal, S., Msimanga-Radebe, B., Rodolph, M. & Baggaley, R. Going global: the adoption of the World Health Organization\u2019s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex. Health. 15 (6), 489\u2013500. https:\/\/doi.org\/10.1071\/sh18125 (2018).","journal-title":"Sex. Health"},{"issue":"3","key":"46956_CR23","doi-asserted-by":"publisher","first-page":"e26059","DOI":"10.1002\/jia2.26059","volume":"26","author":"N Peer","year":"2023","unstructured":"Peer, N. et al. Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta-analysis. J. Int. AIDS. Soc. 26 (3), e26059. https:\/\/doi.org\/10.1002\/jia2.26059 (2023).","journal-title":"J. Int. AIDS. Soc."},{"issue":"1","key":"46956_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejphar.2011.10.007","volume":"672","author":"E Moutzouri","year":"2011","unstructured":"Moutzouri, E., Tsimihodimos, V., Rizos, E., Elisaf, M. & Prediabetes To treat or not to treat? Eur. J. Pharmacol. 672 (1), 9\u201319. https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.007 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"46956_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri, B. et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed. Pharmacother. 107, 306\u2013328. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.157 (2018).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"46956_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-022-00600-6","volume":"19","author":"CE Diggins","year":"2022","unstructured":"Diggins, C. E., Russo, S. C. & Lo, J. Metabolic Consequences of Antiretroviral Therapy. Curr. HIV\/AIDS. Rep. 19 (2), 141\u2013153. https:\/\/doi.org\/10.1007\/s11904-022-00600-6 (2022).","journal-title":"Curr. HIV\/AIDS. Rep."},{"issue":"null","key":"46956_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/RRED.S16496","volume":"1","author":"KE Kumar","year":"2011","unstructured":"Kumar, K. E. & Mastan, S. Effect of protease inhibitors (indinavir and ritonavir) on the pharmacokinetics of gliclazide in rabbits. Res. Rep. Endocr. Disorders. 1 (null), 1\u20139. https:\/\/doi.org\/10.2147\/RRED.S16496 (2011).","journal-title":"Res. Rep. Endocr. Disorders"},{"issue":"2","key":"46956_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pdi.1929","volume":"32","author":"R Kennedy","year":"2015","unstructured":"Kennedy, R., McGoldrick, C. & Zidovudine Practical Diabetes ; 32(2):76\u201377. doi:https:\/\/doi.org\/10.1002\/pdi.1929 (2015).","journal-title":"Practical Diabetes"},{"issue":"11","key":"46956_CR29","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1002\/jmv.27977","volume":"94","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Real-life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients. J. Med. Virol. 94 (11), 5465\u20135474. https:\/\/doi.org\/10.1002\/jmv.27977 (2022).","journal-title":"J. Med. Virol."},{"issue":"4","key":"46956_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.hfc.2012.06.012","volume":"8","author":"JA Kim","year":"2012","unstructured":"Kim, J. A., Montagnani, M., Chandrasekran, S. & Quon, M. J. Role of lipotoxicity in endothelial dysfunction. Heart Fail. Clin. 8 (4), 589\u2013607. https:\/\/doi.org\/10.1016\/j.hfc.2012.06.012 (2012).","journal-title":"Heart Fail. Clin."},{"key":"46956_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.arteri.2021.02.007","volume":"33","author":"T Padro","year":"2021","unstructured":"Padro, T., Mu\u00f1oz-Garcia, N. & Badimon, L. The role of triglycerides in the origin and progression of atherosclerosis. Cl\u00ednica e Investigaci\u00f3n en Arterioscler. 33, 20\u201328. https:\/\/doi.org\/10.1016\/j.arteri.2021.02.007 (2021).","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arterioscler."},{"issue":"6","key":"46956_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","volume":"167","author":"KM Ali","year":"2012","unstructured":"Ali, K. M., Wonnerth, A., Huber, K. & Wojta, J. Cardiovascular disease risk reduction by raising HDL cholesterol \u2013 current therapies and future opportunities. Br. J. Pharmacol. 167 (6), 1177\u20131194. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02081.x (2012).","journal-title":"Br. J. Pharmacol."},{"issue":"25","key":"46956_CR33","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","volume":"29","author":"SC Pal","year":"2023","unstructured":"Pal, S. C. & M\u00e9ndez-S\u00e1nchez, N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J. Gastroenterol. 29 (25), 3999\u20134008. https:\/\/doi.org\/10.3748\/wjg.v29.i25.3999 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"46956_CR34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacl.2018.04.001","volume":"12","author":"BK Gillard","year":"2018","unstructured":"Gillard, B. K., Rosales, C., Xu, B., Gotto, A. M. Jr. & Pownall, H. J. Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins. J. Clin. Lipidol. 12 (4), 849\u2013856. https:\/\/doi.org\/10.1016\/j.jacl.2018.04.001 (2018).","journal-title":"J. Clin. Lipidol."},{"key":"46956_CR35","doi-asserted-by":"publisher","unstructured":"Jiang, H. et al. Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front. Cardiovasc. Med. 9\u20132022. https:\/\/doi.org\/10.3389\/fcvm.2022.925923 (2022).","DOI":"10.3389\/fcvm.2022.925923"},{"issue":"3","key":"46956_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/cid\/ciy083","volume":"67","author":"DV Glidden","year":"2018","unstructured":"Glidden, D. V. et al. Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine. Clin. Infect. Dis. 67 (3), 411\u2013419. https:\/\/doi.org\/10.1093\/cid\/ciy083 (2018).","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"46956_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3851\/imp2305","volume":"17","author":"G Behrens","year":"2012","unstructured":"Behrens, G. et al. Switching to Tenofovir\/Emtricitabine from Abacavir\/ Lamivudine in HIV-Infected Adults with Raised Cholesterol: Effect on Lipid Profiles. Antivir. Ther. 17 (6), 1011\u20131020. https:\/\/doi.org\/10.3851\/imp2305 (2012).","journal-title":"Antivir. Ther."},{"issue":"5","key":"46956_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bj.2017.06.007","volume":"40","author":"S Hurrle","year":"2017","unstructured":"Hurrle, S. & Hsu, W. H. The etiology of oxidative stress in insulin resistance. Biomedical J. 40 (5), 257\u2013262. https:\/\/doi.org\/10.1016\/j.bj.2017.06.007 (2017).","journal-title":"Biomedical J."},{"key":"46956_CR39","doi-asserted-by":"publisher","first-page":"8416763","DOI":"10.1155\/2017\/8416763","volume":"2017","author":"G Pizzino","year":"2017","unstructured":"Pizzino, G. et al. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 8416763. https:\/\/doi.org\/10.1155\/2017\/8416763 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"46956_CR40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/biom14060697","volume":"14","author":"S Anwar","year":"2024","unstructured":"Anwar, S. et al. Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management. Biomolecules 14 (6), 697 (2024).","journal-title":"Biomolecules"},{"issue":"2","key":"46956_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gene.2012.04.011","volume":"501","author":"A Crawford","year":"2012","unstructured":"Crawford, A. et al. Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501 (2), 89\u2013103. https:\/\/doi.org\/10.1016\/j.gene.2012.04.011 (2012).","journal-title":"Gene"},{"issue":"8","key":"46956_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/bph.13828","volume":"175","author":"Q Chen","year":"2018","unstructured":"Chen, Q., Wang, Q., Zhu, J., Xiao, Q. & Zhang, L. Reactive oxygen species: key regulators in vascular health and diseases. Br. J. Pharmacol. 175 (8), 1279\u20131292. https:\/\/doi.org\/10.1111\/bph.13828 (2018).","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"46956_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/qai.0000000000000529","volume":"68","author":"JR Castillo-Mancilla","year":"2015","unstructured":"Castillo-Mancilla, J. R. et al. Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals. J. Acquir. Immune Defic. Syndr. 68 (5), 495\u2013501. https:\/\/doi.org\/10.1097\/qai.0000000000000529 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"15","key":"46956_CR44","doi-asserted-by":"publisher","first-page":"8418","DOI":"10.3390\/ijms25158418","volume":"25","author":"S Barroso","year":"2024","unstructured":"Barroso, S. et al. Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Na\u00efve People with HIV. Int. J. Mol. Sci. 25 (15), 8418 (2024).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"46956_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.52547\/rbmb.11.3.421","volume":"11","author":"H Yousif Hussin Alimam","year":"2022","unstructured":"Yousif Hussin Alimam, H. et al. Blood Glucose, HbA1c Level, and its Correlation with VEGF-A (+\u2009405G\/C) Polymorphism as Biomarker Predicts the Risk of Retinopathy and Nephropathy in Type 2 Diabetic Patients. Rep. Biochem. Mol. Biol. 11 (3), 421\u2013429. https:\/\/doi.org\/10.52547\/rbmb.11.3.421 (2022).","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"1","key":"46956_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","volume":"21","author":"C Xue","year":"2023","unstructured":"Xue, C. et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell. Communication Signal. 21 (1), 298. https:\/\/doi.org\/10.1186\/s12964-022-01016-w (2023).","journal-title":"Cell. Communication Signal."},{"key":"46956_CR47","doi-asserted-by":"publisher","unstructured":"Zhang, A., Fang, H., Chen, J., He, L. & Chen, Y. Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy. Front. Physiol. 11\u20132020. https:\/\/doi.org\/10.3389\/fphys.2020.01064 (2020).","DOI":"10.3389\/fphys.2020.01064"},{"issue":"1","key":"46956_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12882-018-0909-2","volume":"19","author":"CE Anderson","year":"2018","unstructured":"Anderson, C. E. et al. The association of angiogenic factors and chronic kidney disease. BMC Nephrol. 19 (1), 117. https:\/\/doi.org\/10.1186\/s12882-018-0909-2 (2018).","journal-title":"BMC Nephrol."},{"issue":"1","key":"46956_CR49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4102\/sajhivmed.v19i1.817","volume":"19","author":"WDF Venter","year":"2018","unstructured":"Venter, W. D. F., Fabian, J. & Feldman, C. An overview of tenofovir and renal disease for the HIV-treating clinician. South. Afr. J. HIV Med. 19 (1), 817. https:\/\/doi.org\/10.4102\/sajhivmed.v19i1.817 (2018).","journal-title":"South. Afr. J. HIV Med."},{"issue":"8","key":"46956_CR50","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier, M. & Damianaki, A. Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease. Circul. Res. 132 (8), 1050\u20131063. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321762 (2023).","journal-title":"Circul. Res."},{"key":"46956_CR51","first-page":"307","volume-title":"Hypertension: from basic research to clinical practice","author":"SM Hamrahian","year":"2017","unstructured":"Hamrahian, S. M. & Falkner, B. Hypertension in Chronic Kidney Disease. In Hypertension: from basic research to clinical practice (ed. Islam, M. S.) 307\u2013325 (Springer International Publishing, 2017)."},{"key":"46956_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","volume":"12","author":"C Camar\u00e9","year":"2017","unstructured":"Camar\u00e9, C., Pucelle, M., N\u00e8gre-Salvayre, A. & Salvayre, R. Angiogenesis in the atherosclerotic plaque. Redox Biol. 12, 18\u201334. https:\/\/doi.org\/10.1016\/j.redox.2017.01.007 (2017).","journal-title":"Redox Biol."},{"issue":"1","key":"46956_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12981-024-00620-9","volume":"21","author":"GH Taylor","year":"2024","unstructured":"Taylor, G. H. & Pandit, N. S. Angiolipoma associated with antiretroviral switch therapy: a case report. AIDS Res. Therapy. 21 (1), 30. https:\/\/doi.org\/10.1186\/s12981-024-00620-9 (2024).","journal-title":"AIDS Res. Therapy"},{"key":"46956_CR54","doi-asserted-by":"publisher","unstructured":"Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. Endothelial Barrier and Its Abnormalities in Cardiovascular Disease. Front. Physiol. 6\u20132015. https:\/\/doi.org\/10.3389\/fphys.2015.00365 (2015).","DOI":"10.3389\/fphys.2015.00365"},{"issue":"12","key":"46956_CR55","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/jcb.30344","volume":"123","author":"A Ahmad","year":"2022","unstructured":"Ahmad, A. & Nawaz, M. I. Molecular mechanism of VEGF and its role in pathological angiogenesis. J. Cell. Biochem. 123 (12), 1938\u20131965. https:\/\/doi.org\/10.1002\/jcb.30344 (2022).","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"46956_CR56","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41581-021-00429-z","volume":"17","author":"M Carlstr\u00f6m","year":"2021","unstructured":"Carlstr\u00f6m, M. Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat. Rev. Nephrol. 17 (9), 575\u2013590. https:\/\/doi.org\/10.1038\/s41581-021-00429-z (2021).","journal-title":"Nat. Rev. Nephrol."},{"issue":"10","key":"46956_CR57","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/biology10101041","volume":"10","author":"GM da Silva","year":"2021","unstructured":"da Silva, G. M. et al. Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors. Biology 10 (10), 1041 (2021).","journal-title":"Biology"},{"issue":"6","key":"46956_CR58","doi-asserted-by":"publisher","first-page":"F1665","DOI":"10.1152\/ajprenal.00495.2006","volume":"292","author":"T Nakagawa","year":"2007","unstructured":"Nakagawa, T. Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am. J. Physiology-Renal Physiol. 292 (6), F1665\u2013F72. https:\/\/doi.org\/10.1152\/ajprenal.00495.2006 (2007).","journal-title":"Am. J. Physiology-Renal Physiol."},{"issue":"8","key":"46956_CR59","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3851\/imp2752","volume":"19","author":"M Auclair","year":"2014","unstructured":"Auclair, M., Afonso, P., Capel, E., Caron-Debarle, M. & Capeau, J. Impact of Darunavir, Atazanavir and Lopinavir Boosted with Ritonavir on Cultured Human Endothelial Cells: Beneficial Effect of Pravastatin. Antivir. Ther. 19 (8), 773\u2013782. https:\/\/doi.org\/10.3851\/imp2752 (2014).","journal-title":"Antivir. Ther."},{"issue":"10","key":"46956_CR60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai, H. & Harrison, D. G. Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress. Circul. Res. 87 (10), 840\u2013844. https:\/\/doi.org\/10.1161\/01.RES.87.10.840 (2000).","journal-title":"Circul. Res."},{"issue":"2","key":"46956_CR61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cvr\/cvq105","volume":"87","author":"DO Bates","year":"2010","unstructured":"Bates, D. O. Vascular endothelial growth factors and vascular permeability. Cardiovascular. Res. 87 (2), 262\u2013271. https:\/\/doi.org\/10.1093\/cvr\/cvq105 (2010).","journal-title":"Cardiovascular. Res."},{"key":"46956_CR62","doi-asserted-by":"publisher","unstructured":"Kostov, K. The Causal Relationship between Endothelin-1 and Hypertension: Focusing on Endothelial Dysfunction, Arterial Stiffness, Vascular Remodeling, and Blood Pressure Regulation. Life (Basel). 11 (9). https:\/\/doi.org\/10.3390\/life11090986 (2021).","DOI":"10.3390\/life11090986"},{"issue":"5","key":"46956_CR63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.metabol.2003.12.002","volume":"53","author":"H Kakizawa","year":"2004","unstructured":"Kakizawa, H. et al. The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 53 (5), 550\u2013555. https:\/\/doi.org\/10.1016\/j.metabol.2003.12.002 (2004).","journal-title":"Metabolism"},{"issue":"6","key":"46956_CR64","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.phrs.2011.01.012","volume":"63","author":"A Ergul","year":"2011","unstructured":"Ergul, A. Endothelin-1 and diabetic complications: Focus on the vasculature. Pharmacol. Res. 63 (6), 477\u2013482. https:\/\/doi.org\/10.1016\/j.phrs.2011.01.012 (2011).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"46956_CR65","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s43042-022-00303-y","volume":"23","author":"TA Omar","year":"2022","unstructured":"Omar, T. A. et al. Vascular endothelial growth factor A with two genetic variants for prediction of mixed microvascular diabetic complications. Egypt. J. Med. Hum. Genet. 23 (1), 93. https:\/\/doi.org\/10.1186\/s43042-022-00303-y (2022).","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"2","key":"46956_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/hr.2016.128","volume":"40","author":"CS du Plooy","year":"2017","unstructured":"du Plooy, C. S., Martha Cornelia Mels, C., Huisman, H. W. & Kruger, R. The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study. Hypertens. Res. 40 (2), 189\u2013195. https:\/\/doi.org\/10.1038\/hr.2016.128 (2017).","journal-title":"Hypertens. Res."},{"issue":"1","key":"46956_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1124\/jpet.108.142612","volume":"328","author":"K Sachidanandam","year":"2009","unstructured":"Sachidanandam, K. et al. Differential effects of diet-induced dyslipidemia and hyperglycemia on mesenteric resistance artery structure and function in type 2 diabetes. J. Pharmacol. Exp. Ther. 328 (1), 123\u2013130. https:\/\/doi.org\/10.1124\/jpet.108.142612 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"46956_CR68","doi-asserted-by":"publisher","unstructured":"Gumede, N. & Khathi, A. The role of fibrinolysis in the development of prediabetes-associated coronary heart disease: a focus on the plasminogen activator inhibitor\u2009\u2013\u20091 and its potential use as a predictive marker in diet-induced prediabetes. Front. Nutr. 10\u20132023. https:\/\/doi.org\/10.3389\/fnut.2023.1256427 (2023).","DOI":"10.3389\/fnut.2023.1256427"},{"issue":"3","key":"46956_CR69","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/000331970505600304","volume":"56","author":"A Kurita","year":"2005","unstructured":"Kurita, A., Matsui, T., Ishizuka, T., Takase, B. & Satomura, K. Significance of Plasma Nitric Oxide\/Endothelial-1 Ratio for Prediction of Coronary Artery Disease. Angiology 56 (3), 259\u2013264. https:\/\/doi.org\/10.1177\/000331970505600304 (2005).","journal-title":"Angiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46956-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46956-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:16:27Z","timestamp":1779923787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46956-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46956"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46956-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval has been obtained from the University of Pretoria Faculty of Health Sciences, Research Ethics Committee to conduct this research (Animal ethics number 133\/2024). The animal studies were conducted in accordance with the guidelines of the University of Pretoria\u2019s animal ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"all the authors have given their consent for publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"16512"}}